CVS is expanding its CarePass program—which includes home drug delivery—nationwide, the pharmacy giant announced Monday.
CVS Pharmacy, the healthcare giant’s retail arm, said CarePass will be available across the country for $5 per month or $48 per year and will include one- to two-day home delivery on eligible prescriptions.
The goal, CVS said, is to make it easier for customers to manage their medications.
“We are thrilled to expand CarePass nationally, bringing simplified value to our customers while making it easier for them to care for themselves and their families,” Kevin Hourican, executive vice president for CVS Health and president of CVS Pharmacy, said in a statement.
RELATED: CVS announces new initiatives targeting the social determinants of health
The home drug delivery space is shaping up to be a competitive one, as Amazon—which is in the process of launching its healthcare firm Haven along with Berkshire Hathaway and JPMorgan Chase—owns online pharmacy PillPack and its nationwide pharmaceutical distribution network.
Other groups, such as UPS, have also been testing home delivery for pharmaceutical products, like vaccines.
Lindsay Bealor Greenleaf, director at ADVI Health, said that CVS’ size in the pharmacy space is something competitors in the space will be wary of.
"CVS’ market presence would be a concerning factor for anyone trying to enter this market,” she told FierceHealthcare. “They hold such a large market that it would make it hard for anyone to compete.”
RELATED: CVS Caremark to expand diabetes program to preventive, hypertension care
CVS’ CarePass also includes other options for members, including access to an around-the-clock pharmacy helpline and discounts on products in the store. CVS said it plans to continue evolving the program to add new features as well.
The nationwide rollout follows a pilot in several select markets, during which CVS found that the program appeals to a diverse customer base—20% of its users in the initial phases, the company said, were millennials.
The program led to an increase of between 15% and 20% in purchases in the test markets, according to CVS.